Grown Rogue International (GRUSF) Income from Continuing Operations (2018 - 2026)

Grown Rogue International (GRUSF) recorded quarterly Income from Continuing Operations of 2213391.0 in Q1 2026, up 42.78% quarter-over-quarter from 3868338.0 in Q4 2025, and down 397.95% on a YoY basis from 742870.0 in Q1 2025.

Grown Rogue International (GRUSF) Income from Continuing Operations (2018 - 2026) Analysis & Trends

Grown Rogue International's Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 2213391.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations fell 397.95% year-over-year to 2213391.0; the TTM figure through Mar 2026 stood at 837085640026.28 (up 152949093.24% YoY), while the FY2025 annual figure was 2621662.0, up 158.0% from the prior year.
  • Income from Continuing Operations was 2213391.0 for Q1 2026 at Grown Rogue International, up from 3868338.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1709983000000.0 in Q3 2025 to a low of 872891278244.72 in Q2 2025.
  • Historically, Income from Continuing Operations has averaged 55806229607.23 across 5 years, with a median of 742870.0 in 2025.
  • Biggest YoY gain for Income from Continuing Operations was 238831302.76% in 2025; the steepest drop was 15476993.38% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 601273.0 in 2022, then rose by 11.83% to 672427.0 in 2023, then slumped by 1074.31% to 6551517.0 in 2024, then surged by 40.96% to 3868338.0 in 2025, then surged by 42.78% to 2213391.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 2213391.0 (Q1 2026), 3868338.0 (Q4 2025), and 1709983000000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 370.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Grown Rogue International - - 3.96 Mn -2.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.21 Mn
Dec 31, 2025 -3.87 Mn
Sep 30, 2025 1,709.98 Bn
Jun 30, 2025 -872.89 Bn
Mar 31, 2025 742,870.00
Dec 31, 2024 -6.55 Mn
Sep 30, 2024 715,979.13
Jun 30, 2024 5.64 Mn
Mar 31, 2024 1.12 Mn
Dec 31, 2023 672,427.00
Oct 31, 2023 1.65 Mn
Jul 31, 2023 1.55 Mn
Apr 30, 2023 920,853.00
Jan 31, 2023 746,309.00
Jan 31, 2022 601,273.00
Oct 31, 2021 1.62 Mn
Jul 31, 2021 764,360.00
Apr 30, 2021 -586,589.00
Jan 31, 2021 -978,539.00
Oct 31, 2020 -610,383.00